FDA urged to publish follow-up studies on covid-19 vaccine safety signals, BMJ

FDA has been criticised for taking>1 year to follow up potential increase in serious adverse effects (MI, disseminated intravascular coagulation, immune thrombocytopenia& PE) in elderly given Pfizer vaccine. FDA state release of the study findings is expected later this autumn.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news